Evidence map›Paper›PMID 23743231›Full record

ArticleGenomics2013

Whole exome sequencing reveals minimal differences between cell line and whole blood derived DNA.

Chad M Schafer, Nicholas G Campbell, Guiqing Cai, Fei Yu, Vladimir Makarov, Seungtai Yoon, Mark J Daly, Richard A Gibbs, Gerard D Schellenberg, Bernie Devlin and 3 more

Abstract readComparative Study
In one paragraph

Article in Genomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Chad M SchaferDepartment of Statistics, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Nicholas G Campbell
Guiqing Cai
Fei Yu
Vladimir Makarov
Seungtai Yoon
Mark J Daly
Richard A Gibbs
Gerard D Schellenberg
Bernie Devlin
James S Sutcliffe
Joseph D Buxbaum
Kathryn Roeder

Funding

The Human Genome Sequencing CenterU54HG003273 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2004 to 2015
$341.3M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Genetics Association in Schizophrenia and Other DisordersR37MH057881 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEVLIN, BERNIE · 2013 to 2022
$5.4M
5/5 - Elucidating the Genetic Architecture of Autism by Deep Genomic SequencingR01MH089482 · NIMH · VANDERBILT UNIVERSITY · PI SUTCLIFFE, JAMES S · 2009 to 2010
$5.2M
T32 training grant in medical genetics.T32GM082773 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Laszlo Tamas Kozicz, Eva Morava-Kozicz · 2008 to 2026
$4.9M
GENETIC ASSOCIATION IN SCHIZOPHRENIA AND OTHER DISORDERSR01MH057881 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEVLIN, BERNIE · 1998 to 2012
$4.8M
2/5-Elucidating the Genetic Architecture of Autism by Deep Genomic SequencingR01MH089208 · NIMH · BROAD INSTITUTE, INC. · PI DALY, MARK JOSEPH · 2009 to 2010
$4.2M
MOLECULAR GENETICS OF 15Q11-Q13 DEFECTS IN AUTISMR01MH061009 · NIMH · VANDERBILT UNIVERSITY · PI SUTCLIFFE, JAMES S · 2000 to 2008
$3.3M
1/5: Elucidating the Genetic Architecture of Autism by Deep Genomic SequencingR01MH089175 · NIMH · BAYLOR COLLEGE OF MEDICINE · PI GIBBS, RICHARD A · 2009 to 2010
$3.0M
3/5-Elucidating the Genetic Architecture of Autism by Deep Genomic SequencingR01MH089025 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUXBAUM, JOSEPH D. · 2009 to 2010
$1.4M
4/5-Elucidating the Genetic Architecture of Autism by Deep Genomic SequencingR01MH089004 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2010
$1.2M
NCRR NIH HHS UL1 RR024975NHGRI NIH HHS U54 HG003273NICHD NIH HHS P30 HD015052NIGMS NIH HHS T32 GM082773NIMH NIH HHS R01 MH057881NIMH NIH HHS R01 MH061009NIMH NIH HHS R01 MH089004NIMH NIH HHS R01MH089004NIMH NIH HHS R01 MH089025NIMH NIH HHS R01MH089025NIMH NIH HHS R01 MH089175NIMH NIH HHS R01MH089175NIMH NIH HHS R01 MH089208NIMH NIH HHS R01MH089208NIMH NIH HHS R01 MH089482NIMH NIH HHS R37 MH057881
6 · The paper itself

Abstract

Two common sources of DNA for whole exome sequencing (WES) are whole blood (WB) and immortalized lymphoblastoid cell line (LCL). However, it is possible that LCLs have a substantially higher rate of mutation than WB, causing concern for their use in sequencing studies. We compared results from paired WB and LCL DNA samples for 16 subjects, using LCLs of low passage number (<5). Using a standard analysis pipeline we detected a large number of discordant genotype calls (approximately 50 per subject) that we segregated into categories of "confidence" based on read-level quality metrics. From these categories and validation by Sanger sequencing, we estimate that the vast majority of the candidate differences were false positives and that our categories were effective in predicting valid sequence differences, including LCLs with putative mosaicism for the non-reference allele (3-4 per exome). These results validate the use of DNA from LCLs of low passage number for exome sequencing.

Indexed as

ExomeHigh-Throughput Nucleotide SequencingSequence Analysis, DNAAllelesBlood CellsCell LineComputational BiologyGenotypeHumansMosaicismMutationReproducibility of ResultsGraphical diagnosticsLymphoblastoid cell lineMosaicismSequence variant callSomatic mutationStrand bias

Identifiers

PMID23743231
PMCPMC3812417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.